EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

High seroprevalence and high risk: why are older adults more prone to respiratory syncytial virus?

Piotr Rzymski iD, Barbara Poniedziałek, Dorota Zarębska-Michaluk, Krzysztof Tomasiewicz, Robert Flisiak

Journal of Virology · 23.10.2025 · 99 (10)

DOI: 10.1128/jvi.01432-25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Virology, erschienen am 23.10.2025. Verfasst von Piotr Rzymski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Medicine, Poznan University of Medical Sciences, Poznań, Poland. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite widespread seropositivity, respiratory syncytial virus (RSV) remains a major cause of severe illness in adults aged 60 years and older. This review examines why infection-acquired immunity fails to protect this group, focusing on four key factors: structural lung decline, comorbidities, immunosenescence, and impaired antibody responses. Age-related changes weaken mechanical defenses and antiviral immunity, while chronic diseases amplify RSV risk. Critically, repeated RSV infections may preferentially boost non-neutralizing antibodies targeting the postfusion F protein, limiting protection and possibly enhancing disease. The review also highlights how newly approved vaccines, based on stabilized prefusion F protein, can overcome these barriers by inducing strong neutralizing responses, offering a targeted strategy to reduce RSV burden in older adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus, HumanHumansAntibodies, ViralSeroepidemiologic StudiesAgedRespiratory Syncytial Virus VaccinesAntibodies, NeutralizingMiddle AgedAge Factors

Stichwörter der Autor:innen

antibody-dependent enhancementimmunosenescenceolder adultsprefusion F proteinrespiratory syncytial virusvaccination

Substanzen

Antibodies, ViralRespiratory Syncytial Virus VaccinesAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Environmental Medicine, Poznan University of Medical Sciences, Poznań, Poland.
  • Department of Infectious Diseases and Allergology, Jan Kochanowski University, Kielce, Poland.
  • Department of Infectious Diseases, Medical University of Lublin, Lublin, Poland.
  • Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland.

ORCID-Profile: Piotr Rzymski

Förderung

  • Pfizer Poland

Zitieren

APA

Rzymski, P., Poniedziałek, B., Zarębska-Michaluk, D., Tomasiewicz, K., & Flisiak, R. (2025). High seroprevalence and high risk: why are older adults more prone to respiratory syncytial virus?. Journal of Virology, 99(10). https://doi.org/10.1128/jvi.01432-25

Vancouver

Rzymski P, Poniedziałek B, Zarębska-Michaluk D, Tomasiewicz K, Flisiak R. High seroprevalence and high risk: why are older adults more prone to respiratory syncytial virus?. Journal of Virology. 2025;99(10). doi:10.1128/jvi.01432-25

BibTeX
@article{Rzymski2025,
  author = {Rzymski, Piotr and Poniedziałek, Barbara and Zarębska-Michaluk, Dorota and Tomasiewicz, Krzysztof and Flisiak, Robert},
  title = {High seroprevalence and high risk: why are older adults more prone to respiratory syncytial virus?},
  journal = {Journal of Virology},
  year = {2025},
  volume = {99},
  number = {10},
  doi = {10.1128/jvi.01432-25}
}
Kostenlos starten →